Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways-Reference-Cited by-同舟云学术

Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways

Published:2016-03 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhang Yang,Wang Jing-Hao,Zhang Yi-Yuan,Wang Ying-Zhe,Wang Jin,Zhao Yue,Jin Xue-Xin,Xue Gen-Long,Li Peng-Hui,Sun Yi-Lin,Huang Qi-He,Song Xiao-Tong,Zhang Zhi-Ren,Gao Xu,Yang Bao-Feng,Du Zhi-Min,Pan Zhen-Wei

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep23010.pdf

Reference28 articles.

1. Pappachan, J. M., Varughese, G. I., Sriraman, R. & Arunagirinathan, G. Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management. World J Diabetes 4, 177–189 (2013).

2. Galderisi, M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 48, 1548–1551 (2006).

3. Goyal, B. R. & Mehta, A. A. Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion. Hum Exp Toxicol 32, 571–590 (2013).

4. Li, Z., Abdullah, C. S. & Jin, Z. Q. Inhibition of PKC-theta preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy. Br J Pharmacol 171, 2913–2924 (2014).

5. Wang, W. K. et al. Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy. Int J Cardiol 172, 202–212 (2014).

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active Ingredients and Mechanism of Gegen Qinlian Decoction in the Treatment of Diabetic Cardiomyopathy: A Network Pharmacology Study;Current Pharmaceutical Design;2024-08-12

2. Revealing the molecular mechanisms in wound healing and the effects of different physiological factors including diabetes, age, and stress;Journal of Molecular Histology;2024-08-09

3. Ferroptosis in diabetic cardiomyopathy: Advances in cardiac fibroblast-cardiomyocyte interactions;Heliyon;2024-08

4. Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy;Frontiers in Endocrinology;2024-07-30

5. Unraveling the Cardiac Matrix: From Diabetes to Heart Failure, Exploring Pathways and Potential Medications;Biomedicines;2024-06-13